Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201303043 Principal Investigator: Lockhart, A. Craig
Title: Phase II Study of Levocetirizine in Combination with Capecitabine + Bevacizumab to Overcome Resistance to Anti-angiogenic Therapy in Patients with Refractory Colorectal Cancer
Phase: II Disease Site: Colon
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to look at how adding a drug called levocetirizine to a standard treatment for colorectal cancer affects how the patient responds to the treatment, as well as looking at the side effects of this type of treatment.
 
More Information:
Clinicaltrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)